MISC--: angiogenesis plays crucial role variety physiological pathological conditions including cancer cardiovascular disease wound healing
MISC--: vascular endothelial growth factor critical regulator angiogenesis
OWNX--: multiple vegf receptors expressed endothelial cells including signaling receptor tyrosine kinases nonsignaling co receptor neuropilin
OWNX--: neuropilin binds only isoform vegf responsible pathological angiogenesis thus potential target inhibiting vegf signaling
OWNX--: using first molecularly detailed computational model vegf its receptors we shown previously vegfr neuropilin interactions explain observed differential effects vegf isoforms vegf signaling vitro demonstrated potent vegf inhibition antibody neuropilin does not block ligand binding but blocks subsequent receptor coupling
AIMX--: present study we extend computational model simulation vivo vegf transport binding predict vivo efficacy several neuropilin targeted therapies inhibiting vegf signaling blocking neuropilin expression blocking vegf binding neuropilin blocking neuropilin vegfr coupling
MISC--: model predicts blockade neuropilin vegfr coupling significantly more effective than other approaches decreasing vegf vegfr signaling
MISC--: addition tumor types different receptor expression levels respond differently each treatments
MISC--: designing human therapeutics mechanism attacking target plays significant role outcome strategies tested here drugs similar properties neuropilin antibody predicted most effective
OWNX--: tumor type microenvironment target tissue also significant determining therapeutic efficacy each treatments studied
MISC--: angiogenesis growth new blood microvessels preexisting microvasculature critical physiological process growth developing organs during wound healing ovulation pregnancy
MISC--: coronary peripheral ischemia may relieved inducing angiogenesis citation citation while diseases hypervascularization cancer diabetic retinopathy targets anti angiogenic drugs citation citation
MISC--: neuronal expression angiogenic receptors citation citation suggests this work may also relevant development nervous system
MISC--: our goal propose effective targeted therapies using anatomically accurate molecularly detailed computational models growth factors receptors involved angiogenesis
AIMX--: this study we predict three methods targeting same molecule result distinct therapeutic outcomes one methods more effective than others
OWNX--: thus identification therapeutic target must followed rational design targeting molecule obtain characteristics maximize therapeutic potential
OWNX--: addition microenvironment drug act example expression level receptors tissue critical factor impact therapy
MISC--: vascular endothelial growth factor family secreted glycoproteins critical regulators angiogenesis citation citation
MISC--: vitro vegf increases endothelial cell survival proliferation migration
MISC--: vivo increases vascular permeability activates endothelial cells acts chemoattractant nascent vessel sprouts
MISC--: multiple splice isoforms vegf exist two most abundant human vegf vegf
MISC--: both isoforms bind vegf receptor tyrosine kinases induce signals
MISC--: vegf also interacts nonsignaling neuropilin co receptors proteoglycans extracellular matrix citation citation
MISC--: binding sites vegf vegfr neuropilin nonoverlapping so vegf may bind both simultaneously citation
OWNX--: there thus two parallel pathways vegf bind its signaling receptor binding directly vegfr binding neuropilin presents vegf vegfr
MISC--: vegf only form vegfr complexes directly citation
OWNX--: vegf neuropilin interaction thus particular value therapeutic target because vegf isoform vegf been identified inducing pathological angiogenesis citation citation aberrant angiogenic signaling may targeted while allowing normal levels physiological vegf signaling continue
MISC--: previous work citation citation we developed computational models vegf interactions endothelial cell receptors vitro incorporated previously published experimental data estimate kinetic rate vegfr neuropilin coupling vegf
OWNX--: we showed vegfr neuropilin coupling sufficient account observed differential effects vegf isoforms multiple cell types our model reproduces distinct vegf binding signaling effects each cell types citation citation citation
OWNX--: addition we used model distinguish between alternate hypotheses molecular mechanisms action demonstrated neuropilin antibody under investigation acts blocking vegfr neuropilin coupling not blocking vegf neuropilin binding
OWNX--: here we extend validated model molecular interactions vegf family its receptors predict vivo behavior system including ecm basement membranes well multiple cell types geometrical parameters characteristic tissue
MISC--: three methods targeting vegf neuropilin interaction modeled here
MISC--: first blockade neuropilin expression may induced use sirna other methods prevent synthesis protein cells
MISC--: second protein occupies vegf binding site neuropilin compete vegf binding receptor
MISC--: example fragment placental growth factor isoform plgf
MISC--: full length plgf binds neuropilin vegfr citation
MISC--: fragment denoted plgf here contains only neuropilin binding site does not bind vegfr
MISC--: this protein been used block vegf binding neuropilin vitro citation citation
MISC--: alternative would neuropilin binding fragment vegf itself citation citation
OWNX--: third we may block interaction between neuropilins vegfrs preventing presentation vegf signaling receptor but permitting neuropilin sequester isoform
BASE--: this may done using neuropilin antibody citation citation we previously characterized permitting vegf binding neuropilin but blocking subsequent vegfr coupling citation
MISC--: each three strategies been demonstrated inhibit vegf signaling vitro assays citation citation citation citation here we predict their vivo efficacy
OWNX--: this first computational model our knowledge include interactions vegf family their receptors explicitly biophysical detail
OWNX--: model includes kinetics all ligand receptor interactions allows us examine both short term long term behavior system
CONT--: all parameters model been obtained previously published experimental data
OWNX--: analysis characteristic parameters shows kinetics vegf interactions slower than diffusion process so diffusion assumed fast we construct compartmental model parenchymal cells secreting vegf into interstitial space vegf binding receptors endothelial cell surface
MISC--: geometrical parameters tissue under investigation here also incorporated into model interstitial space tumor cell volume surface area microvessel volume surface area
MISC--: changes parameters would result changes kinetic parameters concentrations model
MISC--: results presented here therefore tissue specific but model may applied other tissues
OWNX--: vegfr primary signaling receptor vegf we first analyze results model tissue endothelial cells express vegfr neuropilin but not vegfr effect vegfr considered later
MISC--: initially system steady state vegf secreted parenchymal cells internalized endothelial cells resulting flux through interstitial space ecm
MISC--: one three treatments initiated at time zero time course vegf binding followed hours
MISC--: vegf vegfr vegf vegfr binding taken surrogate vegf signaling
